{"transactions":[{"id":4630920,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-10-05T21:27:13.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning August 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":20000,"derivative":{"exercise_price":1.64,"expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001823197-26-000002","document":"form4-10052026_091008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823197/000182319726000002/form4-10052026_091008.xml","form_type":"4"}},{"id":4630917,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20835,"kind":"person","name":"Zaytsev Evgeny","position":1,"cik":"0001674797","reported_name":"Zaytsev Evgeny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-10-05T21:25:50.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning August 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":20000,"derivative":{"exercise_price":1.64,"expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001674797-26-000007","document":"form4-10052026_091046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674797/000167479726000007/form4-10052026_091046.xml","form_type":"4"}},{"id":4630893,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-10-05T21:24:00.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning August 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":20000,"derivative":{"exercise_price":1.64,"expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001825009-26-000003","document":"form4-10052026_091056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825009/000182500926000003/form4-10052026_091056.xml","form_type":"4"}},{"id":4630881,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20771,"kind":"person","name":"Shaw Allan","position":1,"cik":"0001626850","reported_name":"Shaw Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-10-05T21:23:01.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning August 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":20000,"derivative":{"exercise_price":1.64,"expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001626850-26-000002","document":"form4-10052026_091056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626850/000162685026000002/form4-10052026_091056.xml","form_type":"4"}},{"id":4630871,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":14164,"kind":"person","name":"WILSON ROBERT N","position":1,"cik":"0001189022","reported_name":"WILSON ROBERT N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-10-05T21:21:40.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning August 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":20000,"derivative":{"exercise_price":1.64,"expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001189022-26-000005","document":"form4-10052026_091035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000118902226000005/form4-10052026_091035.xml","form_type":"4"}},{"id":4627638,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20899,"kind":"person","name":"Hebbar Sudarshan","position":1,"cik":"0001968793","reported_name":"Hebbar Sudarshan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-28T20:29:31.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning September 24, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four year period."}],"balance_after":180000,"derivative":{"exercise_price":1.74,"expiration_date":"2036-09-23","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001968793-26-000007","document":"form4-09282026_080927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1968793/000196879326000007/form4-09282026_080927.xml","form_type":"4"}},{"id":4627633,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53374,"kind":"person","name":"Stauderman Kenneth A.","position":1,"cik":"0001969388","reported_name":"Stauderman Kenneth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-28T20:28:41.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning September 24, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four year period."}],"balance_after":180000,"derivative":{"exercise_price":1.74,"expiration_date":"2036-09-23","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001969388-26-000003","document":"form4-09282026_080937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1969388/000196938826000003/form4-09282026_080937.xml","form_type":"4"}},{"id":4627635,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53375,"kind":"person","name":"Bardin Stephen","position":1,"cik":"0001942596","reported_name":"Bardin Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-28T20:27:38.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning September 24, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four year period."}],"balance_after":190000,"derivative":{"exercise_price":1.74,"expiration_date":"2036-09-23","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001942596-26-000003","document":"form4-09282026_080935.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1942596/000194259626000003/form4-09282026_080935.xml","form_type":"4"}},{"id":4627623,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-28T20:24:42.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning September 24, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four year period."}],"balance_after":360000,"derivative":{"exercise_price":1.74,"expiration_date":"2036-09-23","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001484729-26-000006","document":"form4-09282026_080938.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000148472926000006/form4-09282026_080938.xml","form_type":"4"}},{"id":677222,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20293,"kind":"organization","name":"ALAFI CAPITAL CO LLC","position":1,"cik":"0001216017","reported_name":"ALAFI CAPITAL CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Warrants","published_at":"2026-08-24T21:03:15.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":3529192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The issue date of the Series B Warrants is August 19, 2026."}],"balance_after":3529192,"derivative":{"exercise_price":1,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":3529192},"source":{"system":"sec-edgar","filing":"0000912282-26-001157","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216017/000091228226001157/form4.xml","form_type":"4"}},{"id":677221,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20293,"kind":"organization","name":"ALAFI CAPITAL CO LLC","position":1,"cik":"0001216017","reported_name":"ALAFI CAPITAL CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Warrants","published_at":"2026-08-24T21:03:15.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":3529192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The issue date of the Series A Warrants is August 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The expiration of these Series A Warrants is the earlier of (i) 18 months after the closing date of the Private Placement and (ii) 30 days following the Issuer's public announcement of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480."}],"balance_after":3529192,"derivative":{"exercise_price":0.8033,"underlying":"Common Stock","underlying_shares":3529192},"source":{"system":"sec-edgar","filing":"0000912282-26-001157","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216017/000091228226001157/form4.xml","form_type":"4"}},{"id":678567,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20771,"kind":"person","name":"Shaw Allan","position":1,"cik":"0001626850","reported_name":"Shaw Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-08-21T22:48:52.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":10000,"derivative":{"exercise_price":0.6131,"expiration_date":"2036-08-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001626850-26-000001","document":"form4-08212026_100848.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000162685026000001/form4-08212026_100848.xml","form_type":"4"}},{"id":678566,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-08-21T22:47:28.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":10000,"derivative":{"exercise_price":0.6131,"expiration_date":"2036-08-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001823197-26-000001","document":"form4-08212026_100824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000182319726000001/form4-08212026_100824.xml","form_type":"4"}},{"id":678565,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-08-21T22:45:54.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":10000,"derivative":{"exercise_price":0.6131,"expiration_date":"2036-08-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001825009-26-000002","document":"form4-08212026_100850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000182500926000002/form4-08212026_100850.xml","form_type":"4"}},{"id":678780,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20835,"kind":"person","name":"Zaytsev Evgeny","position":1,"cik":"0001674797","reported_name":"Zaytsev Evgeny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-08-21T22:44:49.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":10000,"derivative":{"exercise_price":0.6131,"expiration_date":"2036-08-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001674797-26-000006","document":"form4-08212026_100845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674797/000167479726000006/form4-08212026_100845.xml","form_type":"4"}},{"id":678779,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20835,"kind":"person","name":"Zaytsev Evgeny","position":1,"cik":"0001674797","reported_name":"Zaytsev Evgeny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2026-08-21T22:44:49.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":1450267,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Bering Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrant may be exercised on or after August 19, 2026 and on or prior to June 25, 2031; provided, however, that the holder will be prohibited, subject to certain exceptions, from exercising such warrant for shares of common stock of the Issuer to the extent that immediately prior to or after giving effect to such exercise, the holder, together with its affiliates and other attribution parties, would own more than 9.99% of the total number of shares of common stock of the Issuer then issued and outstanding, which percentage may be changed at the holder's election to a lower percentage at any time or to a higher percentage upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrant may be exercised on or after August 19, 2026 and on or prior to June 25, 2031; provided, however, that the holder will be prohibited, subject to certain exceptions, from exercising such warrant for shares of common stock of the Issuer to the extent that immediately prior to or after giving effect to such exercise, the holder, together with its affiliates and other attribution parties, would own more than 9.99% of the total number of shares of common stock of the Issuer then issued and outstanding, which percentage may be changed at the holder's election to a lower percentage at any time or to a higher percentage upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held by Bering Partners II, L.P. (\"Bering II\"). Bering Partners II GP, L.L.C. (\"Bering II GP\") is the general partner of Bering II and may be deemed to have voting and dispositive power over the securities held by Bering II. The Reporting Person, a member of the Issuer's board of directors, and Philip Sawyer are the managing members of Bering II GP and may be deemed to have voting and dispositive power with respect to these securities. Each of Bering II GP, the Reporting Person and Mr. Sawyer disclaim beneficial ownership of the securities held by Bering II, except to the extent of such person's pecuniary interest therein."}],"balance_after":1450267,"derivative":{"exercise_price":1,"exercise_date":"2026-08-19","expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":1450267},"source":{"system":"sec-edgar","filing":"0001674797-26-000006","document":"form4-08212026_100845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674797/000167479726000006/form4-08212026_100845.xml","form_type":"4"}},{"id":678778,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20835,"kind":"person","name":"Zaytsev Evgeny","position":1,"cik":"0001674797","reported_name":"Zaytsev Evgeny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2026-08-21T22:44:49.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":1450267,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Bering Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480; provided, however, that the holder will be prohibited, subject to certain exceptions, from exercising such warrant for shares of common stock of the Issuer to the extent that immediately prior to or after giving effect to such exercise, the holder, together with its affiliates and other attribution parties, would own more than 9.99% of the total number of shares of common stock of the Issuer then issued and outstanding, which percentage may be changed at the holder's election to a lower percentage at any time or to a higher percentage upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480; provided, however, that the holder will be prohibited, subject to certain exceptions, from exercising such warrant for shares of common stock of the Issuer to the extent that immediately prior to or after giving effect to such exercise, the holder, together with its affiliates and other attribution parties, would own more than 9.99% of the total number of shares of common stock of the Issuer then issued and outstanding, which percentage may be changed at the holder's election to a lower percentage at any time or to a higher percentage upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held by Bering Partners II, L.P. (\"Bering II\"). Bering Partners II GP, L.L.C. (\"Bering II GP\") is the general partner of Bering II and may be deemed to have voting and dispositive power over the securities held by Bering II. The Reporting Person, a member of the Issuer's board of directors, and Philip Sawyer are the managing members of Bering II GP and may be deemed to have voting and dispositive power with respect to these securities. Each of Bering II GP, the Reporting Person and Mr. Sawyer disclaim beneficial ownership of the securities held by Bering II, except to the extent of such person's pecuniary interest therein."}],"balance_after":1450267,"derivative":{"exercise_price":0.8033,"exercise_date":"2026-08-19","expiration_date":"2027-12-25","underlying":"Common Stock","underlying_shares":1450267},"source":{"system":"sec-edgar","filing":"0001674797-26-000006","document":"form4-08212026_100845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674797/000167479726000006/form4-08212026_100845.xml","form_type":"4"}},{"id":678605,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":14164,"kind":"person","name":"WILSON ROBERT N","position":1,"cik":"0001189022","reported_name":"WILSON ROBERT N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-08-21T22:42:42.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":10000,"derivative":{"exercise_price":0.6131,"expiration_date":"2036-08-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001189022-26-000004","document":"form4-08212026_100838.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189022/000118902226000004/form4-08212026_100838.xml","form_type":"4"}},{"id":678604,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":14164,"kind":"person","name":"WILSON ROBERT N","position":1,"cik":"0001189022","reported_name":"WILSON ROBERT N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2026-08-21T22:42:42.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":1182621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to June 25, 2031; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to June 25, 2031; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."}],"balance_after":1182621,"derivative":{"exercise_price":1,"exercise_date":"2026-08-19","expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":1182621},"source":{"system":"sec-edgar","filing":"0001189022-26-000004","document":"form4-08212026_100838.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189022/000118902226000004/form4-08212026_100838.xml","form_type":"4"}},{"id":678603,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":14164,"kind":"person","name":"WILSON ROBERT N","position":1,"cik":"0001189022","reported_name":"WILSON ROBERT N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2026-08-21T22:42:42.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":1182621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."}],"balance_after":1182621,"derivative":{"exercise_price":0.8033,"exercise_date":"2026-08-19","expiration_date":"2027-12-25","underlying":"Common Stock","underlying_shares":1182621},"source":{"system":"sec-edgar","filing":"0001189022-26-000004","document":"form4-08212026_100838.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189022/000118902226000004/form4-08212026_100838.xml","form_type":"4"}},{"id":678994,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20899,"kind":"person","name":"Hebbar Sudarshan","position":1,"cik":"0001968793","reported_name":"Hebbar Sudarshan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Warrant","published_at":"2026-08-21T22:40:57.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":124486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to June 25, 2031; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."}],"balance_after":124486,"derivative":{"exercise_price":1,"exercise_date":"2026-08-19","expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":124486},"source":{"system":"sec-edgar","filing":"0001968793-26-000006","document":"form4-08212026_100852.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1968793/000196879326000006/form4-08212026_100852.xml","form_type":"4"}},{"id":678993,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20899,"kind":"person","name":"Hebbar Sudarshan","position":1,"cik":"0001968793","reported_name":"Hebbar Sudarshan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Warrant","published_at":"2026-08-21T22:40:57.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":124486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."}],"balance_after":124486,"derivative":{"exercise_price":0.8033,"exercise_date":"2026-08-19","expiration_date":"2027-12-25","underlying":"Common Stock","underlying_shares":124486},"source":{"system":"sec-edgar","filing":"0001968793-26-000006","document":"form4-08212026_100852.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1968793/000196879326000006/form4-08212026_100852.xml","form_type":"4"}},{"id":678564,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Warrant","published_at":"2026-08-21T22:36:41.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":186729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after August 19, 2026 and on or prior to June 25, 2031; provided, however, that the holder will be prohibited, subject to certain exceptions, from exercising such warrant for shares of common stock of the Issuer to the extent that immediately prior to or after giving effect to such exercise, the holder, together with its affiliates and other attribution parties, would own more than 19.99% of the total number of shares of common stock of the Issuer then issued and outstanding, which percentage may be changed at the holder's election to a lower percentage at any time or to a higher percentage upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after August 19, 2026 and on or prior to June 25, 2031; provided, however, that the holder will be prohibited, subject to certain exceptions, from exercising such warrant for shares of common stock of the Issuer to the extent that immediately prior to or after giving effect to such exercise, the holder, together with its affiliates and other attribution parties, would own more than 19.99% of the total number of shares of common stock of the Issuer then issued and outstanding, which percentage may be changed at the holder's election to a lower percentage at any time or to a higher percentage upon 61 days' notice to the Issuer."}],"balance_after":186729,"derivative":{"exercise_price":1,"exercise_date":"2026-08-19","expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":186729},"source":{"system":"sec-edgar","filing":"0001576244-26-000005","document":"form4-08212026_100837.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000157624426000005/form4-08212026_100837.xml","form_type":"4"}},{"id":678563,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Warrant","published_at":"2026-08-21T22:36:41.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":186729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug\nAdministration for CM5480; provided, however, that the holder will be prohibited, subject to certain exceptions, from exercising such warrant for shares of common stock of the Issuer to the extent that immediately prior to or after giving effect to such exercise, the holder, together with its affiliates and other attribution parties, would own more than 19.99% of the total number of shares of common stock of the Issuer then issued and outstanding, which percentage may be changed at the holder's election to a lower percentage at any time or to a higher percentage upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug\nAdministration for CM5480; provided, however, that the holder will be prohibited, subject to certain exceptions, from exercising such warrant for shares of common stock of the Issuer to the extent that immediately prior to or after giving effect to such exercise, the holder, together with its affiliates and other attribution parties, would own more than 19.99% of the total number of shares of common stock of the Issuer then issued and outstanding, which percentage may be changed at the holder's election to a lower percentage at any time or to a higher percentage upon 61 days' notice to the Issuer."}],"balance_after":186729,"derivative":{"exercise_price":0.8033,"exercise_date":"2026-08-19","expiration_date":"2027-12-25","underlying":"Common Stock","underlying_shares":186729},"source":{"system":"sec-edgar","filing":"0001576244-26-000005","document":"form4-08212026_100837.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000157624426000005/form4-08212026_100837.xml","form_type":"4"}},{"id":678736,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Warrant","published_at":"2026-08-21T22:35:36.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":186729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to June 25, 2031; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to June 25, 2031; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."}],"balance_after":186729,"derivative":{"exercise_price":1,"exercise_date":"2026-08-19","expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":186729},"source":{"system":"sec-edgar","filing":"0001484729-26-000005","document":"form4-08212026_100832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000148472926000005/form4-08212026_100832.xml","form_type":"4"}},{"id":678735,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Warrant","published_at":"2026-08-21T22:35:36.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":186729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."}],"balance_after":186729,"derivative":{"exercise_price":0.8033,"exercise_date":"2026-08-19","expiration_date":"2027-12-25","underlying":"Common Stock","underlying_shares":186729},"source":{"system":"sec-edgar","filing":"0001484729-26-000005","document":"form4-08212026_100832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000148472926000005/form4-08212026_100832.xml","form_type":"4"}},{"id":713610,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20835,"kind":"person","name":"Zaytsev Evgeny","position":1,"cik":"0001674797","reported_name":"Zaytsev Evgeny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-07-07T21:00:59.000Z","date":"2026-07-02","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest in equal monthly installments over a three year period following the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.9654,"expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001674797-26-000004","document":"form4-07072026_090755.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674797/000167479726000004/form4-07072026_090755.xml","form_type":"4"}},{"id":723867,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":34786,"kind":"person","name":"Middleton Fred A","position":1,"cik":"0001267959","reported_name":"Middleton Fred A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-06-29T12:45:12.000Z","date":"2026-06-25","kind":"purchase","planned":false,"acquired":true,"shares":248972,"price":0.8033,"value":199999.2076,"ownership":{"direct":false,"nature":"By Sanderling Venture Partners VI Co-Investment Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI Co-Investment Fund, LP (\"SVP VI Co-Investment, LP\", together with Sanderling Venture Partners VI, LP., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (the \"Sanderling VI Securities\"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein."}],"balance_after":1063272,"source":{"system":"sec-edgar","filing":"0001267959-26-000003","document":"form4-06292026_080608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267959/000126795926000003/form4-06292026_080608.xml","form_type":"4"}},{"id":724219,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20899,"kind":"person","name":"Hebbar Sudarshan","position":1,"cik":"0001968793","reported_name":"Hebbar Sudarshan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T12:45:10.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":124486,"price":0.8033,"value":99999.6038,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":186025,"source":{"system":"sec-edgar","filing":"0001968793-26-000004","document":"form4-06292026_080607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1968793/000196879326000004/form4-06292026_080607.xml","form_type":"4"}},{"id":723840,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":14164,"kind":"person","name":"WILSON ROBERT N","position":1,"cik":"0001189022","reported_name":"WILSON ROBERT N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-29T12:45:09.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":1182621,"price":0.8033,"value":949999.4493,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":1604650,"source":{"system":"sec-edgar","filing":"0001189022-26-000002","document":"form4-06292026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189022/000118902226000002/form4-06292026_080605.xml","form_type":"4"}},{"id":723769,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2026-06-29T12:45:07.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":186729,"price":0.8033,"value":149999.4057,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":366435,"source":{"system":"sec-edgar","filing":"0001576244-26-000004","document":"form4-06292026_080603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000157624426000004/form4-06292026_080603.xml","form_type":"4"}},{"id":723951,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-29T12:45:05.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":186729,"price":0.8033,"value":149999.4057,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":317655,"source":{"system":"sec-edgar","filing":"0001484729-26-000004","document":"form4-06292026_080601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000148472926000004/form4-06292026_080601.xml","form_type":"4"}},{"id":813165,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53375,"kind":"person","name":"Bardin Stephen","position":1,"cik":"0001942596","reported_name":"Bardin Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-08T01:50:22.000Z","date":"2025-04-05","kind":"grant","planned":false,"acquired":true,"shares":67728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period, provided, however, that no shares shall vest until the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual \"evergreen\" provision."}],"balance_after":67728,"derivative":{"exercise_price":0.585,"expiration_date":"2036-04-04","underlying":"Common Stock","underlying_shares":67728},"source":{"system":"sec-edgar","filing":"0001942596-26-000002","document":"form4-04072026_090411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000194259626000002/form4-04072026_090411.xml","form_type":"4"}},{"id":813555,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20899,"kind":"person","name":"Hebbar Sudarshan","position":1,"cik":"0001968793","reported_name":"Hebbar Sudarshan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-08T01:50:12.000Z","date":"2025-04-05","kind":"grant","planned":false,"acquired":true,"shares":91173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period, provided, however, that no shares shall vest until the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual \"evergreen\" provision."}],"balance_after":91173,"derivative":{"exercise_price":0.585,"expiration_date":"2036-04-04","underlying":"Common Stock","underlying_shares":91173},"source":{"system":"sec-edgar","filing":"0001968793-26-000002","document":"form4-04072026_090409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1968793/000196879326000002/form4-04072026_090409.xml","form_type":"4"}},{"id":813164,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-08T01:50:11.000Z","date":"2025-04-05","kind":"grant","planned":false,"acquired":true,"shares":83358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period, provided, however, that no shares shall vest until the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual \"evergreen\" provision."}],"balance_after":83358,"derivative":{"exercise_price":0.585,"expiration_date":"2036-04-04","underlying":"Common Stock","underlying_shares":83358},"source":{"system":"sec-edgar","filing":"0001576244-26-000002","document":"form4-04072026_090407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000157624426000002/form4-04072026_090407.xml","form_type":"4"}},{"id":813554,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53429,"kind":"person","name":"Dunn Michael J.","position":1,"cik":"0001968792","reported_name":"Dunn Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-08T01:50:09.000Z","date":"2025-04-05","kind":"grant","planned":false,"acquired":true,"shares":65124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period, provided, however, that no shares shall vest until the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual \"evergreen\" provision."}],"balance_after":65124,"derivative":{"exercise_price":0.585,"expiration_date":"2036-04-04","underlying":"Common Stock","underlying_shares":65124},"source":{"system":"sec-edgar","filing":"0001968792-26-000002","document":"form4-04072026_090405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1968792/000196879226000002/form4-04072026_090405.xml","form_type":"4"}},{"id":813163,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53374,"kind":"person","name":"Stauderman Kenneth A.","position":1,"cik":"0001969388","reported_name":"Stauderman Kenneth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-08T01:50:07.000Z","date":"2025-04-05","kind":"grant","planned":false,"acquired":true,"shares":65124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period, provided, however, that no shares shall vest until the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual \"evergreen\" provision."}],"balance_after":65124,"derivative":{"exercise_price":0.585,"expiration_date":"2036-04-04","underlying":"Common Stock","underlying_shares":65124},"source":{"system":"sec-edgar","filing":"0001969388-26-000002","document":"form4-04072026_090404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000196938826000002/form4-04072026_090404.xml","form_type":"4"}},{"id":813386,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-08T01:50:06.000Z","date":"2025-04-05","kind":"grant","planned":false,"acquired":true,"shares":148482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period, provided, however, that no shares shall vest until the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual \"evergreen\" provision."}],"balance_after":148482,"derivative":{"exercise_price":0.585,"expiration_date":"2036-04-04","underlying":"Common Stock","underlying_shares":148482},"source":{"system":"sec-edgar","filing":"0001484729-26-000002","document":"form4-04072026_090402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000148472926000002/form4-04072026_090402.xml","form_type":"4"}},{"id":1019028,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-10-14T16:22:17.000Z","date":"2025-10-13","kind":"grant","planned":false,"acquired":true,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning October 1, 2025, 1/3rd of the shares subject to the option shall vest in equal monthly installments."}],"balance_after":937,"derivative":{"exercise_price":3.26,"expiration_date":"2035-10-12","underlying":"Common Stock","underlying_shares":937},"source":{"system":"sec-edgar","filing":"0001823197-25-000003","document":"form4-10142025_041014.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000182319725000003/form4-10142025_041014.xml","form_type":"4"}},{"id":1034232,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-09-22T13:35:04.000Z","date":"2025-09-18","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":3.07,"value":7675.0,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"balance_after":84150,"source":{"system":"sec-edgar","filing":"0001576244-25-000007","document":"form4-09222025_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000157624425000007/form4-09222025_090901.xml","form_type":"4"}},{"id":1037315,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-09-17T13:45:05.000Z","date":"2025-09-15","kind":"purchase","planned":false,"acquired":true,"shares":3400,"price":2.6779,"value":9104.86,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $2.6779, and the range of prices were between $2.65 and $2.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":81650,"source":{"system":"sec-edgar","filing":"0001576244-25-000005","document":"form4-09172025_090902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000157624425000005/form4-09172025_090902.xml","form_type":"4"}},{"id":1040142,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-09-15T16:31:52.000Z","date":"2025-09-12","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.12,"value":15600.0,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"balance_after":78250,"source":{"system":"sec-edgar","filing":"0001576244-25-000003","document":"form4-09152025_040948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000157624425000003/form4-09152025_040948.xml","form_type":"4"}},{"id":1042547,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-09-11T16:00:07.000Z","date":"2025-09-09","kind":"purchase","planned":false,"acquired":true,"shares":2343,"price":3.1488,"value":7377.6384,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $3.1488, and the range of prices were between $2.75 and $3.21. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":73250,"source":{"system":"sec-edgar","filing":"0001415889-25-024256","document":"form4-09112025_120901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925024256/form4-09112025_120901.xml","form_type":"4"}},{"id":1051216,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-09-02T17:05:22.000Z","date":"2025-08-29","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":2.74,"value":2192.0,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"balance_after":70907,"source":{"system":"sec-edgar","filing":"0001415889-25-023364","document":"form4-09022025_050918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925023364/form4-09022025_050918.xml","form_type":"4"}},{"id":1051215,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-09-02T17:05:22.000Z","date":"2025-08-28","kind":"purchase","planned":false,"acquired":true,"shares":9200,"price":2.863,"value":26339.6,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $2.8630, and the range of prices were between $2.75 and $2.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":70107,"source":{"system":"sec-edgar","filing":"0001415889-25-023364","document":"form4-09022025_050918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925023364/form4-09022025_050918.xml","form_type":"4"}},{"id":1056609,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-08-25T13:30:05.000Z","date":"2025-08-21","kind":"purchase","planned":false,"acquired":true,"shares":3508,"price":2.7928,"value":9797.1424,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $2.7928, and the range of prices were between $2.75 and $2.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":60907,"source":{"system":"sec-edgar","filing":"0001415889-25-022850","document":"form4-08252025_090801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925022850/form4-08252025_090801.xml","form_type":"4"}},{"id":1059066,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-21T16:00:10.000Z","date":"2025-08-20","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":1.53,"value":22950.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":57750,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-25-022550","document":"form4-08212025_120804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925022550/form4-08212025_120804.xml","form_type":"4"}},{"id":1059065,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-08-21T16:00:10.000Z","date":"2025-08-20","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":1.53,"value":22950.0,"ownership":{"direct":true},"balance_after":179706,"source":{"system":"sec-edgar","filing":"0001415889-25-022550","document":"form4-08212025_120804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925022550/form4-08212025_120804.xml","form_type":"4"}},{"id":1059064,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-08-21T16:00:10.000Z","date":"2025-08-20","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.72,"value":5440.0,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"balance_after":57399,"source":{"system":"sec-edgar","filing":"0001415889-25-022550","document":"form4-08212025_120804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925022550/form4-08212025_120804.xml","form_type":"4"}},{"id":1059063,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-08-21T16:00:10.000Z","date":"2025-08-19","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.79,"value":2790.0,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"balance_after":55399,"source":{"system":"sec-edgar","filing":"0001415889-25-022550","document":"form4-08212025_120804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925022550/form4-08212025_120804.xml","form_type":"4"}},{"id":1059422,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20899,"kind":"person","name":"Hebbar Sudarshan","position":1,"cik":"0001968793","reported_name":"Hebbar Sudarshan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-21T16:00:08.000Z","date":"2025-08-19","kind":"purchase","planned":false,"acquired":true,"shares":9563,"price":2.8194,"value":26961.9222,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $2.8194, and the range of prices were between $2.74 and $2.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":61539,"source":{"system":"sec-edgar","filing":"0001415889-25-022549","document":"form4-08212025_120801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1968793/000141588925022549/form4-08212025_120801.xml","form_type":"4"}},{"id":1061365,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-08-19T17:45:06.000Z","date":"2025-08-15","kind":"purchase","planned":false,"acquired":true,"shares":5076,"price":2.8977,"value":14708.7252,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The weighted average purchase price for the transaction reported was $2.8977, and the range of prices were between $2.80 and $2.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":54399,"source":{"system":"sec-edgar","filing":"0001415889-25-022261","document":"form4-08192025_010801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925022261/form4-08192025_010801.xml","form_type":"4"}},{"id":1064186,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20899,"kind":"person","name":"Hebbar Sudarshan","position":1,"cik":"0001968793","reported_name":"Hebbar Sudarshan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-18T16:00:06.000Z","date":"2025-08-15","kind":"purchase","planned":false,"acquired":true,"shares":4392,"price":2.793,"value":12266.856,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction reported was $2.7930, and the range of prices were between $2.70 and $2.85. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":51976,"source":{"system":"sec-edgar","filing":"0001415889-25-022159","document":"form4-08182025_120801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1968793/000141588925022159/form4-08182025_120801.xml","form_type":"4"}},{"id":1064185,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20899,"kind":"person","name":"Hebbar Sudarshan","position":1,"cik":"0001968793","reported_name":"Hebbar Sudarshan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-18T16:00:06.000Z","date":"2025-08-14","kind":"purchase","planned":false,"acquired":true,"shares":1584,"price":2.585,"value":4094.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $2.585, and the range of prices were between $2.57 and $2.61. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":47584,"source":{"system":"sec-edgar","filing":"0001415889-25-022159","document":"form4-08182025_120801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1968793/000141588925022159/form4-08182025_120801.xml","form_type":"4"}},{"id":1079649,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53374,"kind":"person","name":"Stauderman Kenneth A.","position":1,"cik":"0001969388","reported_name":"Stauderman Kenneth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-07-29T20:52:29.000Z","date":"2025-07-28","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3.96,"value":3960.0,"ownership":{"direct":true},"balance_after":12944,"source":{"system":"sec-edgar","filing":"0001415889-25-020458","document":"form4-07292025_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925020458/form4-07292025_040701.xml","form_type":"4"}},{"id":1079648,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53374,"kind":"person","name":"Stauderman Kenneth A.","position":1,"cik":"0001969388","reported_name":"Stauderman Kenneth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-07-29T20:52:29.000Z","date":"2025-07-25","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":3.65,"value":3650.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of the common stock of CalciMedica, Inc. (the \"Issuer\") by the spouse of the reporting person reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person's spouse at a price of $1.85 per share on July 1, 2025. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $1,799.83, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-020458","document":"form4-07292025_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925020458/form4-07292025_040701.xml","form_type":"4"}},{"id":1082707,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-07-23T15:55:44.000Z","date":"2025-07-22","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":3.775,"value":5662.5,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"balance_after":49323,"source":{"system":"sec-edgar","filing":"0001415889-25-020164","document":"form4-07232025_030740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925020164/form4-07232025_030740.xml","form_type":"4"}},{"id":1083264,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-07-22T16:15:14.000Z","date":"2025-07-21","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":3.37,"value":5055.0,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $3.3707, and the range of prices were between $3.33 and $3.43. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":47823,"source":{"system":"sec-edgar","filing":"0001415889-25-020111","document":"form4-07222025_040709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925020111/form4-07222025_040709.xml","form_type":"4"}},{"id":1084003,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-07-21T18:02:43.000Z","date":"2025-07-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3.4,"value":3400.0,"ownership":{"direct":false,"nature":"By Scheibler-Leheny Family Living Trust"},"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001415889-25-020052","document":"form4-07212025_060739.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588925020052/form4-07212025_060739.xml","form_type":"4"}},{"id":1084591,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":14164,"kind":"person","name":"WILSON ROBERT N","position":1,"cik":"0001189022","reported_name":"WILSON ROBERT N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T18:42:42.000Z","date":"2025-07-18","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":2.87,"value":12915.0,"ownership":{"direct":true},"balance_after":422029,"source":{"system":"sec-edgar","filing":"0001415889-25-019998","document":"form4-07182025_060737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189022/000141588925019998/form4-07182025_060737.xml","form_type":"4"}},{"id":1084553,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-07-18T18:36:02.000Z","date":"2025-07-18","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.88,"value":5760.0,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"balance_after":46323,"source":{"system":"sec-edgar","filing":"0001415889-25-019997","document":"form4-07182025_060757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925019997/form4-07182025_060757.xml","form_type":"4"}},{"id":1086381,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-07-16T16:58:34.000Z","date":"2025-07-14","kind":"purchase","planned":false,"acquired":true,"shares":6500,"price":2.4323,"value":15809.95,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $2.4323, and the range of prices were between $2.30 and $2.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":44323,"source":{"system":"sec-edgar","filing":"0001415889-25-019822","document":"form4-07162025_040730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925019822/form4-07162025_040730.xml","form_type":"4"}},{"id":1087342,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-07-16T01:29:14.000Z","date":"2025-07-14","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.47,"value":6175.0,"ownership":{"direct":false,"nature":"By Scheibler-Leheny Family Living Trust"},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001415889-25-019816","document":"form4-07162025_010710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588925019816/form4-07162025_010710.xml","form_type":"4"}},{"id":1089154,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-07-11T00:18:59.000Z","date":"2025-07-09","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.6047,"value":8023.5,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"balance_after":37823,"source":{"system":"sec-edgar","filing":"0001415889-25-019655","document":"form4-07112025_120755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925019655/form4-07112025_120755.xml","form_type":"4"}},{"id":1094389,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53374,"kind":"person","name":"Stauderman Kenneth A.","position":1,"cik":"0001969388","reported_name":"Stauderman Kenneth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-07-03T01:48:24.000Z","date":"2025-07-01","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.85,"value":1850.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001415889-25-019190","document":"form4-07032025_010721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925019190/form4-07032025_010721.xml","form_type":"4"}},{"id":1099923,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-06-27T23:35:22.000Z","date":"2025-06-26","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":1.4406,"value":6482.7,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $1.4406, and the range of prices were between $1.43 and $1.4499. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":32823,"source":{"system":"sec-edgar","filing":"0001415889-25-018438","document":"form4-06272025_110619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018438/form4-06272025_110619.xml","form_type":"4"}},{"id":1101177,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20899,"kind":"person","name":"Hebbar Sudarshan","position":1,"cik":"0001968793","reported_name":"Hebbar Sudarshan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-26T22:31:33.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":83300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":83300,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":83300},"source":{"system":"sec-edgar","filing":"0001415889-25-018310","document":"form4-06262025_100630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1968793/000141588925018310/form4-06262025_100630.xml","form_type":"4"}},{"id":1100867,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53375,"kind":"person","name":"Bardin Stephen","position":1,"cik":"0001942596","reported_name":"Bardin Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-26T22:30:22.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F5","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":20000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-018309","document":"form4-06262025_100618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018309/form4-06262025_100618.xml","form_type":"4"}},{"id":1100866,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53375,"kind":"person","name":"Bardin Stephen","position":1,"cik":"0001942596","reported_name":"Bardin Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-26T22:30:22.000Z","date":"2025-06-26","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.5025,"value":3005.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $1.5025, and the range of prices were between $1.45 and $1.54. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,000 shares held by The Bardin Family Trust dated June 4, 2024 (the \"Trust\") which were inadvertently reported as directly owned on the Form 4 filed with the SEC on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"By The Bardin Family Trust dated June 4, 2024."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001415889-25-018309","document":"form4-06262025_100618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018309/form4-06262025_100618.xml","form_type":"4"}},{"id":1100864,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53374,"kind":"person","name":"Stauderman Kenneth A.","position":1,"cik":"0001969388","reported_name":"Stauderman Kenneth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-26T22:29:14.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":47125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":47125,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":47125},"source":{"system":"sec-edgar","filing":"0001415889-25-018308","document":"form4-06262025_100610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018308/form4-06262025_100610.xml","form_type":"4"}},{"id":1100865,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-26T22:28:16.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":72750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":72750,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":72750},"source":{"system":"sec-edgar","filing":"0001415889-25-018307","document":"form4-06262025_100613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018307/form4-06262025_100613.xml","form_type":"4"}},{"id":1101176,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53429,"kind":"person","name":"Dunn Michael J.","position":1,"cik":"0001968792","reported_name":"Dunn Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-26T22:27:25.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":47125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":47125,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":47125},"source":{"system":"sec-edgar","filing":"0001415889-25-018306","document":"form4-06262025_100621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1968792/000141588925018306/form4-06262025_100621.xml","form_type":"4"}},{"id":1101041,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-26T22:26:23.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":77625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":77625,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":77625},"source":{"system":"sec-edgar","filing":"0001415889-25-018305","document":"form4-06262025_100619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588925018305/form4-06262025_100619.xml","form_type":"4"}},{"id":1100863,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:25:13.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following June 24, 2025, provided that the shares will in any case be fully vested on the date of Company's 2026 annual meeting of stockholders"}],"balance_after":10000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018304","document":"form4-06262025_100609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018304/form4-06262025_100609.xml","form_type":"4"}},{"id":1100862,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:25:13.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/9th of the shares subject to the option vest in equal monthly installments over a one year period following April 1, 2025."}],"balance_after":15000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-25-018304","document":"form4-06262025_100609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018304/form4-06262025_100609.xml","form_type":"4"}},{"id":1100861,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:25:13.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":5000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-25-018304","document":"form4-06262025_100609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018304/form4-06262025_100609.xml","form_type":"4"}},{"id":1100860,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:25:13.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 26, 2025."}],"balance_after":10000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018304","document":"form4-06262025_100609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018304/form4-06262025_100609.xml","form_type":"4"}},{"id":1100859,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:23:49.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following June 24, 2025, provided that the shares will in any case be fully vested on the date of Company's 2026 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018303","document":"form4-06262025_100646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018303/form4-06262025_100646.xml","form_type":"4"}},{"id":1100858,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:23:49.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/9th of the shares subject to the option vest in equal monthly installments over a one year period following April 1, 2025."}],"balance_after":15000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-25-018303","document":"form4-06262025_100646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018303/form4-06262025_100646.xml","form_type":"4"}},{"id":1100857,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:23:49.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":4166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":4166,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":4166},"source":{"system":"sec-edgar","filing":"0001415889-25-018303","document":"form4-06262025_100646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018303/form4-06262025_100646.xml","form_type":"4"}},{"id":1100856,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20770,"kind":"person","name":"Glicklich Alan","position":1,"cik":"0001823197","reported_name":"Glicklich Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:23:49.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 26, 2025."}],"balance_after":10000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018303","document":"form4-06262025_100646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018303/form4-06262025_100646.xml","form_type":"4"}},{"id":1100855,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20771,"kind":"person","name":"Shaw Allan","position":1,"cik":"0001626850","reported_name":"Shaw Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:21:28.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following June 24, 2025, provided that the shares will in any case be fully vested on the date of Company's 2026 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018300","document":"form4-06262025_100625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018300/form4-06262025_100625.xml","form_type":"4"}},{"id":1100854,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20771,"kind":"person","name":"Shaw Allan","position":1,"cik":"0001626850","reported_name":"Shaw Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:21:28.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/9th of the shares subject to the option vest in equal monthly installments over a one year period following April 1, 2025."}],"balance_after":26250,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001415889-25-018300","document":"form4-06262025_100625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018300/form4-06262025_100625.xml","form_type":"4"}},{"id":1100853,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20771,"kind":"person","name":"Shaw Allan","position":1,"cik":"0001626850","reported_name":"Shaw Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:21:28.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":8594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":8594,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":8594},"source":{"system":"sec-edgar","filing":"0001415889-25-018300","document":"form4-06262025_100625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018300/form4-06262025_100625.xml","form_type":"4"}},{"id":1100852,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20771,"kind":"person","name":"Shaw Allan","position":1,"cik":"0001626850","reported_name":"Shaw Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:21:28.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 26, 2025."}],"balance_after":10000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018300","document":"form4-06262025_100625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018300/form4-06262025_100625.xml","form_type":"4"}},{"id":1100936,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":14164,"kind":"person","name":"WILSON ROBERT N","position":1,"cik":"0001189022","reported_name":"WILSON ROBERT N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:20:04.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following June 24, 2025, provided that the shares will in any case be fully vested on the date of Company's 2026 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018298","document":"form4-06262025_100600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189022/000141588925018298/form4-06262025_100600.xml","form_type":"4"}},{"id":1100935,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":14164,"kind":"person","name":"WILSON ROBERT N","position":1,"cik":"0001189022","reported_name":"WILSON ROBERT N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:20:04.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":36562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/9th of the shares subject to the option vest in equal monthly installments over a one year period following April 1, 2025."}],"balance_after":36562,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":36562},"source":{"system":"sec-edgar","filing":"0001415889-25-018298","document":"form4-06262025_100600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189022/000141588925018298/form4-06262025_100600.xml","form_type":"4"}},{"id":1100934,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":14164,"kind":"person","name":"WILSON ROBERT N","position":1,"cik":"0001189022","reported_name":"WILSON ROBERT N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:20:04.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":12031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":12031,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":12031},"source":{"system":"sec-edgar","filing":"0001415889-25-018298","document":"form4-06262025_100600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189022/000141588925018298/form4-06262025_100600.xml","form_type":"4"}},{"id":1100933,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":14164,"kind":"person","name":"WILSON ROBERT N","position":1,"cik":"0001189022","reported_name":"WILSON ROBERT N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:20:04.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 26, 2025."}],"balance_after":10000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018298","document":"form4-06262025_100600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189022/000141588925018298/form4-06262025_100600.xml","form_type":"4"}},{"id":1100961,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":34786,"kind":"person","name":"Middleton Fred A","position":1,"cik":"0001267959","reported_name":"MIDDLETON FRED A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:18:33.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following June 24, 2025, provided that the shares will in any case be fully vested on the date of Company's 2026 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018297","document":"form4-06262025_100629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267959/000141588925018297/form4-06262025_100629.xml","form_type":"4"}},{"id":1100960,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":34786,"kind":"person","name":"Middleton Fred A","position":1,"cik":"0001267959","reported_name":"MIDDLETON FRED A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:18:33.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":19687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/9th of the shares subject to the option vest in equal monthly installments over a one year period following April 1, 2025."}],"balance_after":19687,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":19687},"source":{"system":"sec-edgar","filing":"0001415889-25-018297","document":"form4-06262025_100629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267959/000141588925018297/form4-06262025_100629.xml","form_type":"4"}},{"id":1100959,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":34786,"kind":"person","name":"Middleton Fred A","position":1,"cik":"0001267959","reported_name":"MIDDLETON FRED A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:18:33.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":6562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":6562,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":6562},"source":{"system":"sec-edgar","filing":"0001415889-25-018297","document":"form4-06262025_100629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267959/000141588925018297/form4-06262025_100629.xml","form_type":"4"}},{"id":1100958,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":34786,"kind":"person","name":"Middleton Fred A","position":1,"cik":"0001267959","reported_name":"MIDDLETON FRED A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:18:33.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 26, 2025."}],"balance_after":10000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018297","document":"form4-06262025_100629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267959/000141588925018297/form4-06262025_100629.xml","form_type":"4"}},{"id":1111101,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-06-13T21:05:04.000Z","date":"2025-06-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.85,"value":9250.0,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"balance_after":28323,"source":{"system":"sec-edgar","filing":"0001415889-25-017250","document":"form4-06132025_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925017250/form4-06132025_050601.xml","form_type":"4"}},{"id":1117479,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-06-09T20:08:15.000Z","date":"2025-06-06","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.775,"value":8875.0,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction reported was $1.755, and the range of prices were between $1.75 and $1.87. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":23323,"source":{"system":"sec-edgar","filing":"0001415889-25-016218","document":"form4-06092025_080603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925016218/form4-06092025_080603.xml","form_type":"4"}},{"id":1117478,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20768,"kind":"person","name":"Roberts Eric W","position":1,"cik":"0001576244","reported_name":"Roberts Eric W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2025-06-09T20:08:15.000Z","date":"2025-06-05","kind":"purchase","planned":false,"acquired":true,"shares":5100,"price":1.7,"value":8670.0,"ownership":{"direct":false,"nature":"By FMTC Custodian - Roth IRA FBO Eric W. Roberts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $1.70, and the range of prices were between $1.6638 an $1.7274. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":18323,"source":{"system":"sec-edgar","filing":"0001415889-25-016218","document":"form4-06092025_080603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925016218/form4-06092025_080603.xml","form_type":"4"}},{"id":1124306,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53375,"kind":"person","name":"Bardin Stephen","position":1,"cik":"0001942596","reported_name":"Bardin Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T21:10:11.000Z","date":"2025-05-30","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.69,"value":1690.0,"ownership":{"direct":true},"balance_after":41000,"source":{"system":"sec-edgar","filing":"0001415889-25-015421","document":"form4-06032025_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925015421/form4-06032025_050601.xml","form_type":"4"}},{"id":1165479,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53375,"kind":"person","name":"Bardin Stephen","position":1,"cik":"0001942596","reported_name":"Bardin Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-25T20:35:02.000Z","date":"2025-04-23","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning March 26, 2025, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period."}],"balance_after":130000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001415889-25-011365","document":"form4-04252025_080459.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925011365/form4-04252025_080459.xml","form_type":"4"}},{"id":1165478,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53374,"kind":"person","name":"Stauderman Kenneth A.","position":1,"cik":"0001969388","reported_name":"Stauderman Kenneth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-25T20:34:05.000Z","date":"2025-04-23","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning March 26, 2025, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period."}],"balance_after":125000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-25-011362","document":"form4-04252025_080402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925011362/form4-04252025_080402.xml","form_type":"4"}},{"id":1165790,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":53429,"kind":"person","name":"Dunn Michael J.","position":1,"cik":"0001968792","reported_name":"Dunn Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-25T20:33:07.000Z","date":"2025-04-23","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning March 26, 2025, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period."}],"balance_after":125000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-25-011361","document":"form4-04252025_080404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1968792/000141588925011361/form4-04252025_080404.xml","form_type":"4"}}],"next_cursor":"2025-04-25T20:33:07.000000Z,1165790"}